SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

nLIGHT, Inc. engages in the provision of semiconductor and fiber lasers for aerospace and defense, industrial, and microfabrication applications. It operates through the Laser Products and Advanced Development segments. The Laser Products segment designs, manufactures, and sells a range of semiconductor lasers and fiber lasers that are typically integrated into laser systems or manufacturing tools built by customers. The Advanced Development segment focuses on research, design, and prototyping of next-generation laser technologies, leveraging expertise in laser technology, development, beam control, and advanced optics. The company was founded by Scott H. Keeney, Mark DeVito, and Jason Farmer in June 2000 and is headquartered in Camas, WA.

nLIGHT Inc

nLIGHT ($LASR) is trending amidst discussions about defense contracts, particularly the "Golden Dome" project, potentially driving significant growth. Community members are speculating on contract news and the company's laser technology applications in defense, suggesting a possible breakout. Some traders are expressing bullish sentiments, anticipating a short squeeze and setting high sell targets, while others note the stock's high valuation and potential for manipulation.

ARB IOT Group Ltd. is a holding company that engages in the provision of solutions for the integration of IoT systems and devices. It operates through the Internet of Things and Investment Holding and Others segments. The company was founded on March 1, 2022 and is headquartered in Singapore.

ARB IOT Group Ltd

ARBB is trending due to social media hype around its low float and potential for a short squeeze, with many traders eyeing key breakout levels. Community members are actively discussing price targets and comparing ARBB's setup to other recent low-float runners. The stock's recent AI server deal and blockchain developments may also be contributing to the increased attention.

Broadcom Inc. is a global technology company, which designs, develops, and supplies semiconductors and infrastructure software solutions. It operates through the Semiconductor Solutions and Infrastructure Software segments. The Semiconductor Solutions segment refers to product lines and intellectual property licensing. The Infrastructure Software segment relates to mainframe, distributed and cyber security solutions, and the FC SAN business. The company was founded in 1961 and is headquartered in Palo Alto, CA.

Broadcom Inc

Despite strong earnings and AI prospects, Broadcom ($AVGO) is trending down as investors express concerns about margin compression and customer concentration. The community is debating whether this dip represents a buying opportunity or the start of a larger correction in the AI sector. Discussions also focus on potential recovery catalysts and the stock's oversold condition.

Direxion Shares ETF Trust - Direxion Daily S&P Biotech Bull 3X Shares

Direxion Daily S&P Biotech Bull 3X Shares

LABU is trending as traders weigh biotech's potential amid broader market uncertainty and upcoming economic data. Community discussions focus on identifying entry and exit points, with some highlighting technical indicators suggesting a possible shift in momentum. Bullish sentiment remains, fueled by potential rate cuts and sector rotation.

Rivian Automotive, Inc. engages in the design, development, and manufacture of category-defining electric vehicles and accessories. It operates through following segments: Automotive, Software and Services. The company was founded by Robert J. Scaringe in June 2009 and is headquartered in Irvine, CA.

Rivian Automotive Inc - Ordinary Shares - Class A

Rivian Automotive Inc

Rivian is trending as the community discusses its AI & Autonomy Day and the unveiling of its new in-house AI chip, sparking debates about its potential to rival Tesla in the autonomous vehicle space. Bullish sentiment is fueled by Needham's price target increase, while some express concerns regarding cash burn and the timeline for R2 vehicle production. The community is closely watching for a potential short squeeze.

Direxion Shares ETF Trust - Direxion Daily S&P Biotech Bear 3X Shares

Direxion Daily S&P Biotech Bear 3X Shares

LABD is trending as traders discuss potential resistance for XBI around the 111 area, anticipating a possible pullback. Community members are debating entry points and whether current market conditions warrant adding to or reducing positions in this leveraged inverse ETF. Ongoing concerns around potential government shutdowns and trade war escalations are also influencing sentiment.

What Is Pi Network? Pi Network is a social cryptocurrency, developer platform, and ecosystem designed for widespread accessibility and real-world utility. It enables users to mine and transact Pi using a mobile-friendly interface while supporting applications built within its blockchain ecosystem.  Supply Model and Mining Mechanism The Maximum Supply of Pi is 100 billion tokens. The Maximum Supply is comprised of the following: 65 Billion tokens (or 65%) are allocated for all community mining rewards; 10 billion (10%) are allocated for foundation reserves; 5 billion (5%) are allocated for liquidity purposes; and 20 billion (20%) are allocated for the Core Team. Each allocation mentioned above tracks the community Migrated Mining Rewards issuance pace, so the proportions of each allocation in the total supply remains the same at any given time.   The Effective Total Supply of Pi—the total Pi supply at the current time—allocates Pi proportionally the same as the Maximum Supply. Since every allocation tracks the Migrated Mining Rewards of the community, the Effective Total Supply can be calculated by dividing the current Migrated Mining Rewards of Pi on the Mainnet blockchain by 65%. The other allocations within the Effective Total Supply can then be calculated based on the same proportions as the Maximum Supply, e.g. at most 10% of the Effective Total Supply is available in the foundation reserve, 5% of the Effective Total Supply is available for liquidity purposes, and 20% of the Effective Total Supply is available for the Core Team. This remains true despite the fact that all tokens were minted at the genesis as technically required by the blockchain protocol.  Circulating Supply includes all Migrated Mining Rewards and all tokens that entered circulation from other buckets of the allocations, which at its maximum could be summed up to equal the Effective Total Supply.   Pi’s mining rewards are distributed based on an issuance formula that follows a declining exponential model defined in the Pi whitepaper. Users can increase the amount of mining rewards they receive based on their individual contributions to the network, like Security Circles, using utility-based Pi apps, running Nodes, etc. For each month, the amount of Pi to be distributed as mobile balance is capped and determined by the model, regardless of how many people or how many types of mining rewards there are during the month. The capping is achieved by the design of a system-wide base mining rate, and each type of mining rewards to each individual are just a multiplier of this base mining rate. As the monthly supplies always diminish, the base mining rate generally decreases over time.   Fewer Pi may also be issued because the real Pi issuance on the blockchain depends on Pioneers passing KYC and completing all steps required for migration to the Mainnet. Despite all efforts to facilitate and remind Pioneers to complete those required steps, there are always dropoffs along the way, resulting in less than all outstanding mobile balances to be issued on the blockchain. Because of this mechanism, the community issued amount (Migrated Mining Rewards) on the blockchain will likely be closer and closer to a line lower than the 65 billion. This is thus the reason for the variable Effective Total Supply which incorporates this effect. Effective Total Supply results from all Migrated Mining Rewards divided by 65%, as opposed to the Maximum Supply of 100 billion.  Ecosystem and Adoption Pi Network has built an integrated ecosystem that facilitates real-world transactions and decentralized applications. Pi can be used as a medium of exchange for goods and services, including online commerce and local brick-and-mortar businesses.  Users can engage with Core Team and community-built apps in the Pi ecosystem through the Pi Browser, where integrated features like the Pi Wallet provide a seamless experience. Events like PiFest 2024 showcased Pi’s growing adoption, with over 27,000 active sellers and 28,000 test merchants across 160 countries.  Who Are the Founders of Pi Network? Pi Network was founded by Dr. Nicolas Kokkalis and Dr. Chengdiao Fan, both of whom have PhDs from Stanford University and a passion for improving human lives through technology.  Dr. Nicolas Kokkalis is a Stanford PhD in EE and postdoc in CS with research on distributed systems and human-computer interaction. His work focuses on combining distributed systems and human computer interaction to bring cryptocurrency to everyday people. As a strong and long-term believer of the technical, financial and social potential of cryptocurrencies, he is determined to move them beyond their current limitations and is committed to bringing the power of blockchain to more people.  Dr. Chengdiao Fan holds a Stanford PhD in Anthropological Sciences, harnessing social computing to unlock human potential on a global scale. Chengdiao is building Pi Network to mobilize individuals all over the world to participate and be rewarded for their contributions, and establish an inclusive ecosystem for global citizens to unleash and capture their own agency, and in turn create utilities and productions for society and the world.  Compliance and Identity Verification Pi Network follows a one-account-per-person policy through its Know Your Customer (KYC) solution. This system combines machine automation and human verification to authenticate user identities while preserving privacy.  The KYC process emphasizes real individuals, combats fraudulent activities and enables fair participation in the mining process of the network. Pi’s identity verification approach balances scalability, security, and accessibility, allowing millions of users worldwide to validate their accounts while maintaining regulatory compliance.

Pi Network

Pi Network is trending amidst mixed community sentiment, with some users expressing frustration over unverified balances and comparing it to a scam, while others remain optimistic about its long-term potential. Discussions also involve price predictions and speculation around exchange listings, but there is chatter about the numerous promotional posts.

EchoStar Corp. engages in the design, development, and distribution of digital set-top boxes and products for direct-to-home satellite service providers. It operates through the following business segments: Pay-TV, Retail Wireless, and Broadband and Satellite Services. The Pay-TV segment business strategy is to be the best provider of video services in the United States by providing products with the best technology, outstanding customer service, and great value. The Retail Wireless segment offers Retail Wireless services as well as a competitive portfolio of wireless devices. The Broadband and Satellite Services segment business strategy is to maintain and improve leadership position and competitive advantage through development of technologies and services marketed to selected sectors within the consumer, enterprise and government markets globally. The company was founded by Charlie William Ergen, Candy Ergen, and James DeFranco in 1980 and is headquartered in Englewood, CO.

EchoStar Corp - Ordinary Shares - Class A

EchoStar Corp

EchoStar Corp ($SATS) is trending due to speculation surrounding its SpaceX holdings and potential benefits from a SpaceX IPO, with community members weighing the value of its SpaceX stake against the company's debt. Recent news of a spectrum sale to SpaceX and subsequent FCC review adjustments are also fueling the discussion, alongside Morgan Stanley's upgrade and price target increase.  Additionally, Firefly's acquisition of SciTec has sparked conversation about space sector acquisitions and potential bullish moves.

Lumentum Holdings, Inc. engages in the provision of optical and photonic products. It operates through the Cloud and Networking, and Industrial Tech segments. The Cloud and Networking segment refers to a portfolio of optical and photonic components, modules, and subsystems. The Industrial Tech segment includes solid-state lasers, kilowatt-class fiber lasers, ultrafast lasers, diode lasers, and gas lasers. The company was founded in 1979 and is headquartered in San Jose, CA.

Lumentum Holdings Inc

Lumentum ($LITE) is trending due to positive sentiment around its role in AI infrastructure, particularly after strong earnings reports and revenue guidance. Community discussions highlight its potential for growth and undervaluing compared to peers, with some suggesting it's a takeover target. Some are drawing comparisons to names like Nvidia ($NVDA) during their early expansion.

BlackRock Institutional Trust Company N.A. - iShares Russell 2000 ETF

iShares Russell 2000 ETF

IWM is trending as traders evaluate recent market movements, particularly the rotation from large-cap tech into small-cap stocks. Community discussions are focused on potential breakout levels and reactions to upcoming economic reports, with some cautioning about overbought conditions. The ETF's performance is also being analyzed in the context of interest rate expectations and potential policy shifts.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Paul Rubin Sells 18,000 Shares of BioAge Labs (NASDAQ:BIOA) Stock

BioAge Labs, Inc. (NASDAQ:BIOA - Get Free Report) insider Paul Rubin sold 18,000 shares of the stock in a transaction that occurred on Tuesday, December 9th. The stock was sold at an average price of...

BioAge Labs (NASDAQ:BIOA) Insider Sells $216,000.00 in Stock

BioAge Labs, Inc. (NASDAQ:BIOA - Get Free Report) insider Paul Rubin sold 18,000 shares of the business's stock in a transaction that occurred on Tuesday, December 9th. The stock was sold at an...

Paul Rubin Sells 68,897 Shares of BioAge Labs (NASDAQ:BIOA) Stock

BioAge Labs, Inc. (NASDAQ:BIOA - Get Free Report) insider Paul Rubin sold 68,897 shares of the firm's stock in a transaction that occurred on Thursday, December 4th. The stock was sold at an average...

BioAge Labs (NASDAQ:BIOA) Rating Increased to Hold at Wall Street Zen

Wall Street Zen upgraded BioAge Labs from a "sell" rating to a "hold" rating in a report on Saturday...

Jefferies Financial Group Inc. Buys Shares of 50,000 BioAge Labs, Inc. $BIOA

Jefferies Financial Group Inc. bought a new stake in BioAge Labs, Inc. (NASDAQ:BIOA - Free Report) in the second quarter, according to the company in its most recent 13F filing with the Securities...

BioAge Labs (NASDAQ:BIOA) Issues Quarterly Earnings Results

BioAge Labs (NASDAQ:BIOA - Get Free Report) announced its quarterly earnings results on Thursday. The company reported ($0.56) EPS for the quarter, beating analysts' consensus estimates of ($0.67) by...

BioAge Labs’ stock&nbsp;lost more than two-thirds of its market cap in pre-market trading Monday, poised to hit an all-time low following its decision to discontinue the STRIDES Phase 2 study of azelaprag, its investigational obesity drug.&nbsp;The halt, announced on Friday, came after some subjects in the azelaprag treatment arms showed elevated liver enzymes, though no clinically significant symptoms were reported.&nbsp;The tirzepatide-only treatment group did not exhibit transaminase elevations, according to the company.CEO Kristen Fortney said, "We made the difficult decision to discontinue the STRIDES Phase 2 study of azelaprag because it became clear that the emerging safety profile of the current doses tested is inconsistent with our goal of a best-in-class oral obesity therapy.”&nbsp;BioAge said it remains focused on developing therapies for metabolic aging and advancing its NLRP3 inhibitor program alongside other research initiatives.The news spurred swift Wall Street downgrades on Monday.&nbsp;Jefferies cut its rating from ‘Buy’ to ‘Hold’ and slashed its price target from $42 to $7, noting the unexpected liver signal after a clean safety profile in eight prior Phase 1 studies by BioAge and Amgen.&nbsp;Citi also downgraded the stock to ‘Neutral’ from ‘Buy’, reducing its price target from $45 to $7. The brokerage highlighted that the liver toxicity concerns significantly limit azelaprag’s potential in obesity treatments and eliminate a key catalyst for BioAge’s shares.<figure class="image"><a href="https://stocktwits.com/symbol/BIOA"><img style="aspect-ratio:1318/318;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/Screenshot_2024_12_09_at_6_21_42_PM_bad10ec021.png" alt="Screenshot 2024-12-09 at 6.21.42 PM.png" width="1318" height="318"></a><figcaption>BIOA sentiment and message volume on Dec 9 premarket as of 7:45 am ET | source: Stocktwits</figcaption></figure>Retail sentiment on Stocktwits turned sharply ‘bearish’ after the announcement, a reversal from ‘bullish’ levels the previous day.&nbsp;Investors expressed frustration over the trial’s discontinuation and the steep decline in share value.<stembedurl>https://stocktwits.com/ProKnifeCatcher87/message/595559186</stembedurl><stembedurl>https://stocktwits.com/texmade2/message/595509540</stembedurl>BioAge, which had seen strong market interest since its IPO in September amid the weight-loss drug frenzy, is now down over 10% year-to-date.&nbsp;For updates and corrections email newsroom[at]stocktwits[dot]com.

Jefferies cut its rating on BioAge from ‘Buy’ to ‘Hold’ and slashed its price target from $42 to $7

BioAge Stock Nosedives On Obesity Drug Study Halt: Downgrades Crush Retail Sentiment

BioAge, which had seen strong market interest since its IPO in September amid the weight-loss drug frenzy, is now down over 10% year-to-date.

Equity

BioAge, which had seen strong market interest since its IPO in September amid the weight-loss drug frenzy, is now down over 10% year-to-date.


BioAge Labs, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapeutic products for metabolic diseases, such as obesity, by targeting the biology of human beings. It offers Azelaprag, a potential oral therapeutic for obesity, followed by several earlier-stage metabolic programs. The company was founded by Kristen Fortney and Eric Morgen on April 1, 2015 and is headquartered in Emeryville, CA.

Fiscal Period	Estimated	Reported	Surprise	Result
Q4 '25	-$0.77	-$0.81	-5.18%	MISSED
Q3 '25	-$0.58	-$0.56	4.05%	BEAT
Q2 '25	-$0.48	-$0.60	-24.56%	MISSED
Q1 '25	-$0.53	-$0.36	31.95%	BEAT
Q4 '24	-$0.83	--	--	N/A

BIOA
BioAge Labs Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q4 '25

Historical Earnings

Latest BIOA News

BIOABioAge Labs Inc.